173 related articles for article (PubMed ID: 27537549)
1. Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.
Mondal M; Sengupta M; Ray K
Br J Dermatol; 2016 Dec; 175(6):1232-1242. PubMed ID: 27537549
[TBL] [Abstract][Full Text] [Related]
2. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
Dolinska MB; Kus NJ; Farney SK; Wingfield PT; Brooks BP; Sergeev YV
Pigment Cell Melanoma Res; 2017 Jan; 30(1):41-52. PubMed ID: 27775880
[TBL] [Abstract][Full Text] [Related]
3. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.
Oetting WS; Fryer JP; King RA
Hum Mutat; 1998; 12(6):433-4. PubMed ID: 10671066
[TBL] [Abstract][Full Text] [Related]
6. Oculocutaneous albinism type 1B associated with a functionally significant tyrosinase gene polymorphism detected with Whole Exome Sequencing.
Mendez R; Iqbal S; Vishnopolska S; Martinez C; Dibner G; Aliano R; Zaiat J; Biagioli G; Fernandez C; Turjanski A; Campbell AJ; Mercado G; Marti MA
Ophthalmic Genet; 2021 Jun; 42(3):291-295. PubMed ID: 33599182
[No Abstract] [Full Text] [Related]
7. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).
Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE
Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292
[TBL] [Abstract][Full Text] [Related]
8. Electron microscopic DOPA reaction test for oculocutaneous albinism.
Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
[TBL] [Abstract][Full Text] [Related]
9. Functional validation of the albinism-associated tyrosinase T373K SNP by CRISPR/Cas9-mediated homology-directed repair (HDR) in rabbits.
Song Y; Zhang Y; Chen M; Deng J; Sui T; Lai L; Li Z
EBioMedicine; 2018 Oct; 36():517-525. PubMed ID: 30274819
[TBL] [Abstract][Full Text] [Related]
10. Identification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1.
Lu Q; Yuan L; Xu H; Huang X; Yang Z; Yi J; Ni B; Chen Y; Deng H
Mol Med Rep; 2017 Mar; 15(3):1426-1430. PubMed ID: 28112372
[TBL] [Abstract][Full Text] [Related]
11. Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the
Monfermé S; Lasseaux E; Duncombe-Poulet C; Hamel C; Defoort-Dhellemmes S; Drumare I; Zanlonghi X; Dollfus H; Perdomo Y; Bonneau D; Korobelnik JF; Plaisant C; Michaud V; Pennamen P; Rooryck-Thambo C; Morice-Picard F; Paya C; Arveiler B
Br J Ophthalmol; 2019 Sep; 103(9):1239-1247. PubMed ID: 30472657
[TBL] [Abstract][Full Text] [Related]
12. TYR mutation in a Chinese population with oculocutaneous albinism: Molecular characteristics and ophthalmic manifestations.
Chen C; Li J; Wang B; Wang Y; Yu X
Exp Eye Res; 2024 Feb; 239():109761. PubMed ID: 38145795
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1.
Li C; Chen Q; Wu J; Ren J; Zhang M; Wang H; Li J; Tang Y
J Biol Chem; 2022 May; 298(5):101922. PubMed ID: 35413289
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of TYR gene and its structural consequences in OCA1A.
K B; Purohit R
Gene; 2013 Jan; 513(1):184-95. PubMed ID: 23085273
[TBL] [Abstract][Full Text] [Related]
15. A novel missense mutation of the TYR gene in a pedigree with oculocutaneous albinism type 1 from China.
Lin YY; Wei AH; Zhou ZY; Zhu W; He X; Lian S
Chin Med J (Engl); 2011 Oct; 124(20):3358-61. PubMed ID: 22088535
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.
Toyofuku K; Wada I; Spritz RA; Hearing VJ
Biochem J; 2001 Apr; 355(Pt 2):259-69. PubMed ID: 11284711
[TBL] [Abstract][Full Text] [Related]
17. The Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A.
Teramae A; Kobayashi Y; Kunimoto H; Nakajima K; Suzuki T; Tsuruta D; Fukai K
J Invest Dermatol; 2019 May; 139(5):1143-1149. PubMed ID: 30447237
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Homozygous Missense Mutation in the TYR Gene in a Chinese Family with OCA1.
Wang Y; Zhou YF; Shen N; Zhu YW; Tan K; Wang X
Curr Med Sci; 2018 Oct; 38(5):932-936. PubMed ID: 30341532
[TBL] [Abstract][Full Text] [Related]
19. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase.
Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J
Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of a Chinese family with oculocutaneous albinism.
Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
